Hospital-at-home inpatient care is no worse than its traditional counterpart at facilitating good clinical outcomes for comparable overall costs. In fact “HaH” is sometimes considerably better on both those scores.
When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.
“Dr. Matsumoto is a trusted physician leader with a long record of service to the college and a clear commitment to quality, safety and patient-centered care,” ACR CEO Dana H. Smetherman, MD, said May 4.
New findings support the routine use of deep learning-based risk assessments, as this method can decrease subjectivity, reduce unnecessary imaging and improve diagnostic accuracy.
As TAVR continues to gain popularity, researchers remain focused on discovering new ways to predict short- and long-term outcomes. One recent study, for example, explored the potential of AI-enabled imaging assessments. Another analysis focused on the CALLY index.
The 4D system harnesses X-ray diffraction to measure molecular-level signatures of disease; these tissue “fingerprints” could help providers diagnose breast cancer in its earliest stages.
Hospital-at-home inpatient care is no worse than its traditional counterpart at facilitating good clinical outcomes for comparable overall costs. In fact “HaH” is sometimes considerably better on both those scores.
